Cefotaxime vs Ceftriaxone for the Prolongation of Latency Period in Preterm Premature Rupture of Membranes
Keywords:PPROM, Antibiotic, Cefotaxime, Ceftriaxone, Cephalosporin, Latency period
Introduction: Antibiotics are well known and recommended as the main therapy for preterm premature rupture of membranes (PPROM.) But the research on antibiotics other than the recommended macrolides regimens is still lacking. This research aims to evaluate whether there are effects differences of cefotaxime and ceftriaxone given on pregnancy with PPROM by comparing the duration of the latency period and the infants outcomes.
Material and Methods: Data was taken retrospectively through medical records at Dr. Soetomo Surabaya General Hospital, Indonesia during the period of January-December 2017. The inclusion criteria were a history of PPROM in pregnancy <37 weeks, given cefotaxime or ceftriaxone therapy, and have labor data. The analysis was performed by the Mann-Whitney comparison test for the latency period and Fisher's exact test for infant outcomes.
Results: There were 52 samples obtained. The antibiotics used were cefotaxime 3x1gr (A) and ceftriaxone 2x1gr (B). The results of the analysis showed that there were no significant differences between the types of antibiotics with the length of the latency period, with a value of p = 0,601 (p>0,05), where group A had a median of 52,67 hours and group B was 34,17 hours. Group A was found to be more able to extend the latency period for >48 hours with a percentage of 57,8%, whereas in group B only 42,9%. There are no significant differences in infant outcomes; infant birth weight and Apgar score among the two therapies used.
Conclusion: Cefotaxime was more preferably to be used in the Dr. Soetomo Surabaya General Hospital. Nevertheless, ceftriaxone can still be a good choice for PPROM therapy since both cephalosporins have succeeded in preventing infections in women with PPROM.
Medina TM, Hill DA. Preterm premature rupture of membranes:
diagnosis and management. Am Fam Physician 2006; 73(4):659-
Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis
and management of preterm premature rupture of membranes.
Rev Obstet Gynecol 2008; 1(1):11-22.
Mercer BM. Preterm premature rupture of the membranes:
current approaches to evaluation and management. Obstet
Gynecol Clin North Am 2005; 32(3):411-28.
Stock O, Gordon L, Kapoor J, et al. Chorioamnionitis Occurring
in Women With Preterm Rupture of the Fetal Membranes Is
Associated With a Dynamic Increase in mRNAs Coding Cytokines
in the Maternal Circulation. Reprod Sci 2015; 22(7):852-859.
Bowes WA Jr. The role of antibiotics in the prevention of preterm
birth. F1000 Med Rep 2009; 1. pii: 22. doi: 10.3410/M1-22
Johnston MM, Sanchez-Ramos L, Vaughn AJ, Todd MW,
Benrubi GI. Antibiotic therapy in preterm premature rupture of
membranes: a randomized, prospective, double-blind trial. Am
J Obstet Gynecol 1990; 163(3):743-747.
Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm
premature rupture of membranes. Cochrane Database Syst Rev
Melamed N, Hadar E, Ben-Haroush A, Kaplan B, Yogev Y.
Factors affecting the duration of the latency period in preterm
premature rupture of membranes. J Matern Fetal Neonatal Med
Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for preterm
pre-labour rupture of membranes: prevention of neonatal
deaths due to complications of pre-term birth and infection. Int
J Epidemiol 2010; 39 Suppl 1(Suppl 1):134-143.
Schmitz T, Sentilhes L, Lorthe E, Gallot D, Madar H, Doret-Dion
M, Beucher G, Charlier C, Cazanave C, Delorme P, Garabedian
C, Azria Ã‰, Tessier V, Senat MV, Kayem G. Preterm premature
rupture of membranes: CNGOF Guidelines for clinical practice
- Short version. Gynecol Obstet Fertil Senol 2018; 46(12):998-
Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J,
Naberezhnev Y, Winarno AS, Seliger G. Mid-trimester preterm
premature rupture of membranes (PPROM): etiology, diagnosis,
classification, international recommendations of treatment
options and outcome. J Perinat Med 2018; 46(5):465-488.
Machado DCS, Dias JdM, Rosado LEP. Antibiotic prophylaxis
in preterm rupture of membranes. Hum Reprod Arch 2018;
Saghafi N, Pourali L, Ghazvini K, Maleki A, Ghavidel M,
Karbalaeizadeh Babaki M. Cervical bacterial colonization in
women with preterm premature rupture of membrane and
pregnancy outcomes: A cohort study. Int J Reprod Biomed
(Yazd) 2018; 16(5):341-348.
Zeng L, Zhang L, Shi J, Gu L, Grogan W, Gargano MM,
Chen C. The primary microbial pathogens associated with
premature rupture of the membranes in China: A systematic
review. Taiwanese Journal of Obstetric and Gynecology 2014;
Li YY, Kong CW, To WWK. Pathogens in preterm prelabour
rupture of membranes and erythromycin for antibiotic
prophylaxis: a retrospective analysis. Hong Kong Med J 2019;
Adewumi OA, Olofinbiyi BA, Oyekale OT, Loto OM, Abu SH,
Sotunsa JO. Microbiological Pattern in Preterm Prelabour
Rupture of the Fetal Membranes in South-Western Nigeria.
Obstet Gynecol Int J 2017; 6(4):00215
Majdawati A. Pola Kepekaan Kuman Penyebab Infeksi Saluran
Kemih dan Resistensinya. Mutiara Medika 2001; 1:55-63.
Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari
Cheshmeh M, Salehian Omran D. A survey on urinary
tract infections associated with the three most common
uropathogenic bacteria. Maedica (Buchar) 2010; 5(2):111-115.
Thompson RL, Wright AJ. Cephalosporin antibiotics. Mayo
Clinic Proceedings 1983; 58(2):79-87.
Kalman D, Barriere SL. Review of the pharmacology,
pharmacokinetics, and clinical use of cephalosporins. Tex Heart
Inst J 1990; 17(3):203-215.
Klein NC, Cunha BA. Third-generation cephalosporins. Med Clin
North Am 1995; 79(4):705-719.
SÃ¡ Del Fiol F, Gerenutti M, Groppo FC. Antibiotics and pregnancy.
Pharmazie 2005; 60:483-493.
Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G,
Saginur R, Feld R, Duperval R, Landis SJ, Miedzinski LJ, et al.
Once-daily therapy with ceftriaxone compared with daily
multiple-dose therapy with cefotaxime for serious bacterial
infections: a randomized, double-blind study. J Infect Dis 1989;
Smith CR, Petty BG, Hendrix CW, Kernan WN, Garver PL, Fox
K, Beamer A, Carbone K, Threlkeld M, Lietman PS. Ceftriaxone
compared with cefotaxime for serious bacterial infections. J
Infect Dis 1989; 160(3):442-447.
Simmons BP, Gelfand MS, Grogan J, Craft B. Cefotaxime twice
daily versus ceftriaxone once daily. A randomized controlled
study in patients with serious infections. Diagn Microbiol Infect
Dis 1995; 22(1-2):155-157.
Illahi RK, Pramestutie HR, Susilaningtyas WS. Cost-Effectiveness
Analysis of Cefotaxime, Ceftriaxone, and Levofloxacine in
the Treatment of Thyphoid Fever: A Study From Kanjuruhan
Hospital, Malang, Indonesia. Value in Health 2018; 21:S65.
Bonanno C, Wapner RJ. Antenatal corticosteroids in the
management of preterm birth: are we back where we started?.
Obstet Gynecol Clin North Am 2012; 39(1):47-63.
Fortunato SJ, Welt SI, Eggleston M, Cole J, Bryant EC, Dodson
MG. Prolongation of the latency period in preterm premature
rupture of the membranes using prophylactic antibiotics and
tocolysis. J Perinatol 1990; 10(3):252-6.
Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH. A
new antibiotic regimen treats and prevents intra-amniotic
inflammation/infection in patients with preterm PROM. J
Matern Fetal Neonatal Med 2016; 29(17):2727-37.
Kenyon S, Taylor DJ, Tarnow-Mordi WO; ORACLE Collaborative
Group. ORACLE--antibiotics for preterm prelabour rupture of
the membranes: short-term and long-term outcomes. Acta
Paediatr Suppl 2002; 91(437):12-5.
Buitendijk SE. Erythromycin for premature rupture of
membranes is beneficial for infant. Ned Tijdschr Geneeskd
Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli
from clinical sources in northeast Ethiopia. Afr Health Sci 2011;
Suppl 1(Suppl 1):S40-S45.
Seelbach-Goebel B. Antibiotic Therapy for Premature Rupture
of Membranes and Preterm Labor and Effect on Fetal Outcome.
Geburtshilfe Frauenheilkd 2013; 73(12):1218-1227.
Navathe R, Schoen CN, Heidari P, Bachilova S, Ward A, Tepper
J, Visintainer P, Hoffman MK, Smith S, Berghella V, Roman A.
Azithromycin vs erythromycin for the management of preterm
premature rupture of membranes. Am J Obstet Gynecol 2019;
Pierson RC, Gordon SS, Haas DM. A retrospective comparison
of antibiotic regimens for preterm premature rupture of
membranes. Obstet Gynecol 2014; 124(3):515-519.
Gelber S, Brent E, Varrey A, Fridman B, Sapra K, Frayer W.
Equivalence of erythromycin and azithromycin for treatment of
PPROM. Am J Obstet Gynecol 2013; 208(1):S291.
Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das
AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant
morbidity after preterm premature rupture of the membranes: a
randomized controlled trial. JAMA 1997; 278(12):989-995
Desai SV, Tank P. Handbook on Preterm Prelabor Rupture of
Membranes in a Low Resource Setting. JAYPEE 2012; 35-36.
Nadisauskiene R, BergstrÃ¶m S, Kilda A. Ampicillin in the
treatment of preterm labor: a randomised, placebo-controlled
study. Gynecol Obstet Invest 1996; 41(2):89-92.
American Academy Of Pediatrics Committee On Fetus And
Newborn; American College Of Obstetricians And Gynecologists
Committee On Obstetric Practice. The Apgar Score. Pediatrics
Salan YDC. Effect of Length of Premature Rupture of Membranes
Period toward Apgar Score of The Infant and Maternal Leukocyte
Serum in Ulin General Hospital Banjarmasin. Berkala Kedokteran
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|